If you have PCOS or suspect you might, you may have seen headlines about a name change. Here's what actually happened, and what it means for you.
The Short Version
Polycystic Ovary Syndrome (PCOS) is now officially called Polyendocrine Metabolic Ovarian Syndrome (PMOS). The change was announced in May 2026, following a global consensus process published in The Lancet. The process involved 56 academic, clinical, and patient organisations, and drew on surveys of more than 14,000 people with the condition along with health professionals from every world region.
Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide
The American Society for Reproductive Medicine has endorsed the new terminology.
American Society for Reproductive Medicine
Most importantly: the condition itself has not changed. If you were diagnosed with PCOS last year, you have PMOS now. Your body, your diagnosis, your risk profile none of it is different.
Why the Old Name Was a Problem
The name "polycystic ovary syndrome" dates back to 1935, when the condition was believed to originate in the ovaries.
But what appears as "cysts" on an ultrasound isn't what most people picture. These are follicles, normal fluid-filled sacs, each containing an immature egg. They aren't painful, they don't require surgical removal, and they aren't what drives the condition.
The term PCOS was considered inaccurate precisely because it implied pathological ovarian cysts, obscured the condition's endocrine and metabolic features, and contributed to delayed diagnosis, fragmented care, and stigma. Researchers also found no increase in abnormal ovarian cysts in the condition, further supporting the case for change.
What the New Name Actually Describes
Each word in "polyendocrine metabolic ovarian syndrome" was chosen deliberately:
Polyendocrine: this is a hormonal condition involving multiple endocrine systems, not just one. Insulin, androgens, and the signalling between the brain and ovaries are all involved.
Metabolic: insulin resistance is present in the majority of patients, including many who aren't obese, with elevated risks of impaired glucose tolerance, gestational diabetes, dyslipidemia, hypertension, and cardiovascular disease. These aren't side effects. They're part of the condition.
AJMC
Ovarian: the reproductive connection remains real and relevant for fertility, cycle regularity, and pregnancy planning.
Syndrome: this is a collection of related features, not a single disease.
The renaming also recognises that this is not primarily a gynecological disorder, but a complex multisystem condition involving endocrine, metabolic, reproductive, dermatological and psychological health.
CU Anschutz Medical Campus
Why This Matters for Women Here
For many women in Pakistan and across South Asia, a PCOS diagnosis has meant a conversation almost entirely about fertility and very little about anything else.
The metabolic side gets missed. Blood sugar isn't screened. Cardiovascular risk isn't discussed. Weight concerns get dismissed as a willpower issue rather than recognised as part of the condition. Hair fall, skin changes, and mood get treated as separate, unrelated complaints.
This mischaracterisation has had real consequences: delayed diagnoses, fragmented care, stigma, and missed opportunities for early intervention in metabolic and cardiovascular risk.
A name that leads with hormones and metabolism should, over time, change the questions doctors ask and the tests they order.
What Changes for You Practically
Nothing you need to do right now. Diagnostic criteria are the same. Treatment options are the same. Decades of existing research still applies.
You'll see both names for a while. Clinics, lab reports, and patient materials will update at different speeds. Seeing PCOS and PMOS used side by side is normal during the transition.
Medical coding hasn't changed yet. Formal updates to international disease classification systems are still in progress, so PCOS will remain the coded diagnosis on medical records for some time.
The full transition runs over roughly three years, with international guidelines expected to be fully updated by 2028.
What Hasn't Changed at All
The things that have always helped still help. Managing insulin resistance. Maintaining a weight that's healthy for your body. Regular movement. Sleep. Stress management. Getting screened for the metabolic risks that come with this condition, whether or not fertility is currently your concern.
A better name doesn't treat anything. But it does make it harder for your full picture to be overlooked.
Jinan's Inner Balance formula was developed to support hormonal balance and metabolic wellness in both partners. It's intended as supportive care alongside proper medical evaluation and treatment, not as a replacement for either.